tradingkey.logo
搜尋

Co-Diagnostics Inc

CODX
添加自選
1.630USD
+0.030+1.88%
收盤 05/14, 16:00美東報價延遲15分鐘
113.83K總市值
虧損本益比TTM

Co-Diagnostics Inc

1.630
+0.030+1.88%
查看詳細走勢圖
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+1.88%

5天

-15.54%

1月

+18.12%

6月

+392.00%

今年開始到現在

+866.79%

1年

+373.15%

TradingKey Co-Diagnostics Inc股票評分

單位: USD 更新時間: 2026-05-13

操作建議

Co-Diagnostics Inc當前公司基本面數據相對非常健康,最新ESG揭露屬於行業領先水平。增長潛力很大。當前估值合理,在醫療設備與耗材行業排名128/206位。機構持股佔比非常高,近一月多位分析師給出公司評級為持有。最高目標價為30.00。近一個月,市場表現較強,技術面和基本面綜合得分較高,較強的走勢獲得基本面和技術面的印證。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Co-Diagnostics Inc評分

相關信息

行業排名
128 / 206
全市場排名
296 / 4487
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
中性

Co-Diagnostics Inc亮點

亮點風險
Co-Diagnostics, Inc. is a molecular diagnostics company, which develops, manufactures and markets diagnostics technologies. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. It is developing a portable diagnostic device and test system designed for point-of-care and at-home use. The system consists of its PCR instrument that it refers to as the Co-Dx PCR Pro instrument, its proprietary diagnostic test cup system and a mobile application to be installed on the user’s mobile device.
業績增長期
公司處於發展階段,最新年度總收入622.49K美元
利潤高增長
公司淨利潤處於行業前列,最新年度總收入622.49K美元
估值高估
公司最新PE估值-0.00,處於3年歷史高位
機構減倉
最新機構持股248.15K股,環比減少39.01%
詹姆斯·西蒙斯持倉
明星投資者詹姆斯·西蒙斯持倉,最新持倉24.34K股
活躍度降低
近期活躍度降低,過去20天平均換手率-0.81

分析師目標

基於 2 分析師
持有
評級
30.000
目標均價
+1171.19%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Co-Diagnostics Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Co-Diagnostics Inc簡介

Co-Diagnostics, Inc. is a molecular diagnostics company, which develops, manufactures and markets diagnostics technologies. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. It is developing a portable diagnostic device and test system designed for point-of-care and at-home use. The system consists of its PCR instrument that it refers to as the Co-Dx PCR Pro instrument, its proprietary diagnostic test cup system and a mobile application to be installed on the user’s mobile device.
公司代碼CODX
公司Co-Diagnostics Inc
CEOEgan (Dwight H)
網址https://codiagnostics.com/
KeyAI